BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31971041)

  • 1. Novel therapeutics for brain tumors: current practice and future prospects.
    El Demerdash N; Kedda J; Ram N; Brem H; Tyler B
    Expert Opin Drug Deliv; 2020 Jan; 17(1):9-21. PubMed ID: 31971041
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel chemotherapeutics and other therapies for treating high-grade glioma.
    Kang JH; Adamson C
    Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
    Saito R; Tominaga T
    Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convection-Enhanced Delivery for Management of Malignant Gliomas.
    Prabhu SS
    Prog Neurol Surg; 2018; 32():152-158. PubMed ID: 29990981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors.
    Srinivasan VM; Lang FF; Chen SR; Chen MM; Gumin J; Johnson J; Burkhardt JK; Kan P
    J Neurointerv Surg; 2020 Feb; 12(2):197-203. PubMed ID: 31676690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery strategies for the treatment of malignant gliomas.
    Allhenn D; Boushehri MA; Lamprecht A
    Int J Pharm; 2012 Oct; 436(1-2):299-310. PubMed ID: 22721856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel drug delivery strategies in neuro-oncology.
    Bidros DS; Vogelbaum MA
    Neurotherapeutics; 2009 Jul; 6(3):539-46. PubMed ID: 19560743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound.
    Schoen S; Kilinc MS; Lee H; Guo Y; Degertekin FL; Woodworth GF; Arvanitis C
    Adv Drug Deliv Rev; 2022 Jan; 180():114043. PubMed ID: 34801617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
    Ferguson S; Lesniak MS
    Curr Drug Deliv; 2007 Apr; 4(2):169-80. PubMed ID: 17456036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the Delivery of Antineoplastic Therapies to the Central Nervous System.
    Naidoo J; Panday H; Jackson S; Grossman SA
    Oncology (Williston Park); 2016 Nov; 30(11):953-62. PubMed ID: 27854097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
    Drapeau A; Fortin D
    Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic chemotherapy: advances in delivery, pharmacology, and testing.
    Ciordia R; Supko J; Gatineau M; Batchelor T
    Curr Oncol Rep; 2000 Sep; 2(5):445-53. PubMed ID: 11122877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local drug delivery.
    Haroun RI; Brem H
    Curr Opin Oncol; 2000 May; 12(3):187-93. PubMed ID: 10841189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local strategies and delivery systems for the treatment of malignant gliomas.
    Yu F; Asghar S; Zhang M; Zhang J; Ping Q; Xiao Y
    J Drug Target; 2019 Apr; 27(4):367-378. PubMed ID: 30101621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium.
    Doolittle ND; Anderson CP; Bleyer WA; Cairncross JG; Cloughesy T; Eck SL; Guastadisegni P; Hall WA; Muldoon LL; Patel SJ; Peereboom D; Siegal T; Neuwelt EA
    Neuro Oncol; 2001 Jan; 3(1):46-54. PubMed ID: 11305417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomedical engineering approaches to enhance therapeutic delivery for malignant glioma.
    McCrorie P; Vasey CE; Smith SJ; Marlow M; Alexander C; Rahman R
    J Control Release; 2020 Dec; 328():917-931. PubMed ID: 33197488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas.
    Muro K; Das S; Raizer JJ
    Technol Cancer Res Treat; 2006 Jun; 5(3):201-13. PubMed ID: 16700617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.